ENvue Medical (FEED) Change in Accured Expenses (2014 - 2026)
ENvue Medical's (FEED) quarterly Change in Accured Expenses came in at $357000.0 in Q1 2026, down 39.08% year-on-year from $586000.0 in Q1 2025, and up 4.39% on a QoQ basis from $342000.0 in Q4 2025.
ENvue Medical (FEED) Change in Accured Expenses (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 12 years of Change in Accured Expenses data on file, last reported at $357000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 39.08% year-over-year to $357000.0 in Q1 2026; TTM through Mar 2026 was $796000.0, a 1.36% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, up 323.55% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $357000.0, up from $342000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for FEED reached as high as $586000.0 in Q1 2025 and fell as low as -$157000.0 in Q3 2022.
- Historically, Change in Accured Expenses has averaged $99058.8 across 5 years, with a median of $41000.0 in 2023.
- Across the five-year window, Change in Accured Expenses plunged 434.04% in 2022 and surged 2690.48% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at $155000.0 in 2022, then plunged by 150.97% to -$79000.0 in 2023, then soared by 337.97% to $188000.0 in 2024, then jumped by 81.91% to $342000.0 in 2025, then advanced by 4.39% to $357000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $357000.0 in Q1 2026, $342000.0 in Q4 2025, and $27000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ENvue Medical | 10,254.30 | -2.25 Mn | -55,000.00 | 357,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 357,000.00 |
| Mar 31, 2026 | 357,000.00 |
| Dec 31, 2025 | 342,000.00 |
| Dec 31, 2025 | 342,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Mar 31, 2025 | 586,000.00 |
| Mar 31, 2025 | 586,000.00 |
| Dec 31, 2024 | 188,000.00 |
| Dec 31, 2024 | 188,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Dec 31, 2023 | -79,000.00 |